Seeking something new, Airbnb CEO promises 'perfect concierge' — Neutral
ABNB TechXplore — May 14, 2025"Novelty is cool. It's exciting. I want to be new (and) fresh," Airbnb CEO Brian Chesky told AFP in Los Angeles, where he is presenting a new offering that could bring haircuts and other services into your holiday home.

Carnival's Comeback: Is the Stock Set for a Profitable Journey? — Positive
CCL MarketBeat — May 14, 2025The global travel sector is demonstrating renewed vigor, with consumer demand for leisure experiences showing a clear upward trend well into late 2025 and early 2026. Within this revival, the cruise industry is notably buoyant, with passenger volumes widely anticipated to surpass pre-pandemic benchmarks.

4 Utility Stocks to Bet on From the Thriving Electric Power Industry — Positive
CNP DTE ED EVRG Zacks Investment Research — May 14, 2025Amid rising demand for electricity and an increase in the unit price of electricity, utilities like ED, DTE, CNP and EVRG are set to benefit from strong demand from their stable customer base.

Earnings Estimates Moving Higher for Waystar (WAY): Time to Buy? — Positive
WAY Zacks Investment Research — May 14, 2025Waystar (WAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Earnings Estimates Moving Higher for Janus International Group (JBI): Time to Buy? — Positive
JBI Zacks Investment Research — May 14, 2025Janus International Group (JBI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Earnings Estimates Rising for Mayville Engineering (MEC): Will It Gain? — Positive
MEC Zacks Investment Research — May 14, 2025Mayville Engineering (MEC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Can Confluent (CFLT) Run Higher on Rising Earnings Estimates? — Positive
CFLT Zacks Investment Research — May 14, 2025Confluent (CFLT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Palo Alto Earnings Preview: New Kid On The Block Is AI & I'm Buying — Positive
PANW Seeking Alpha — May 14, 2025I'm maintaining Palo Alto Networks with a buy ahead of 3Q25 earnings, due on May 20th, as I expect possible upward guidance revisions. Near-term tailwinds include firewall refresh cycles, market share gains, and a first-mover advantage in AI security through strategic acquisitions like AI Protect. The shift from hardware to software and cloud security positions Palo Alto for long-term growth and profitability, in my opinion.

Cisco Stock Roars Back On AI Firepower, Saudi Pact — Bullish Breakout Faces Q3 Earnings Test — Positive
CSCO Benzinga — May 14, 2025Cisco Systems Inc CSCO will report its third-quarter earnings Wednesday after the market close, with Wall Street expecting earnings per share of 92 cets and revenue of $14.08 billion.

Vodafone Q4 Preview: German Operations Overshadow Other Parts Of The Business — Positive
VOD Seeking Alpha — May 14, 2025Vodafone Group Public Limited Company's Q4 results are expected to show steady growth, with no major surprises anticipated in sales or EPS. German operations remain the key focus due to regulatory headwinds and revenue declines; signs of stabilization or recovery are crucial. UK and Turkey segments are performing well, and continued momentum in these markets, along with Cloud & Security growth, are positive catalysts.

Coca-Cola Beverages Florida Recognized as a 2025 US Best Managed Company — Neutral
KO Business Wire — May 14, 2025TAMPA, Fla.--(BUSINESS WIRE)--Coca-Cola Beverages Florida, LLC (Coke Florida) is proud to announce it has been selected as a 2025 US Best Managed Companies Gold Standard Winner, which honors organizations that have been recognized for four or more years as US Best Managed Companies. Sponsored by Deloitte Private and The Wall Street Journal, the award recognizes the achievements of US private companies and their management teams. “Being selected as a US Best Managed Company for the fourth year i.

Avino Silver Earnings Beat Estimates in Q1, Revenues Jump Y/Y — Positive
ASM Zacks Investment Research — May 14, 2025ASM Q1 results reflect gains from higher metal prices and consistent production.

Alphabet Down 16% YTD: Are GOOGL Shares Buy, Sell or Hold on the Dip? — Negative
GOOG GOOGL Zacks Investment Research — May 14, 2025GOOGL is strengthening its competitive position in search and cloud with the infusion of AI amid challenging macroeconomic conditions.

Coinbase to Join S&P 500, Shares Rally: ETFs to Buy — Positive
COIN Zacks Investment Research — May 14, 2025ETFs are set to gain as Coinbase is set to enter the S&P 500 on May 19.

Exxon Mobil: Tariff Truce Made This Dividend King Less Timely — Positive
XOM Seeking Alpha — May 14, 2025I rate Exxon Mobil as a buy, down from my earlier strong buy rating, due to recent geopolitical and earnings developments impacting its near-term timeliness. XOM's FQ1 2025 earnings showed some unevenness, with forecasts showing further declines for the full year of 2025 before a recovery. I also believe consensus overstated its recovery potential judging by the ROCE and CAPEX plan announced in its earnings report.

Boeing wins significant aircraft order from Qatar Airways — Positive
BA Proactive Investors — May 14, 2025Boeing Co (NYSE:BA, ETR:BCO) has secured a significant aircraft order from Qatar Airways as part of broader economic commitments between the US and Qatar totalling $1.2 trillion, the White House announced on Wednesday. Announced during US President Donald Trump's official visit to Qatar, the nation will purchase from Boeing up to 210 Dreamliner and 777X aircraft powered by GE Aerospace engines.

U.S. FDA Approves EMRELIS™ (telisotuzumab vedotin-tllv) for Adults With Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) With High c-Met Protein Overexpression — Neutral
ABBV PRNewsWire — May 14, 2025– EMRELIS is the first and only treatment approved for previously treated advanced NSCLC patients with high c-Met protein overexpression who often face poor prognosis and have limited treatment options – Lung cancer remains the leading cause of cancer-related deaths throughout the worl d1 NORTH CHICAGO, Ill. , May 14, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that EMRELIS™ (telisotuzumab vedotin-tllv) has been granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with locally advanced or metastatic, non-squamous non-small cell lung cancer (NSCLC) with high c-Met protein overexpression (OE) who have …

Nvidia and Other AI Stocks Climb as Saudi Deals Raise Expectations of More to Come — Positive
NVDA Investopedia — May 14, 2025Nvidia (NVDA) and other AI stocks climbed Wednesday, extending Tuesday's gains as Saudi Arabian partnerships announced during President Donald Trump's four-day trip to the Middle East stoked excitement for future deals.

All You Need to Know About HCI Group (HCI) Rating Upgrade to Buy — Positive
HCI Zacks Investment Research — May 14, 2025HCI Group (HCI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Cardiff Oncology (CRDF) Upgraded to Buy: Here's What You Should Know — Positive
CRDF Zacks Investment Research — May 14, 2025Cardiff Oncology (CRDF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
